Jennifer Lynn Minai-Azary - Feb 13, 2023 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Financial Officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
4
Date filed
2/14/2023, 04:04 PM
Previous filing
Dec 19, 2022
Next filing
Mar 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +158K $0.00 158K Feb 13, 2023 Common Stock 158K $0.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.